Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06337799

Use of Allied-health Professionals to Improve Treatment of Disease

The goal of this clinical trial is to learn if allied-health professionals can recruit and follow research participants, sustain engagement, and improve and diagnose treatment of diseases by facilitating transitions of care.

Participants will:

Take their blood pressure at home and return it to the research team; Follow up with a research pharmacist for 12 months; Return for a follow up visit after 12 months.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Preeclampsia Female Urogenital Diseases and Pregnancy Complications Hypertension, Pregnancy-Induced Pre-Eclampsia Pregnancy Complications Urogenital Diseases

Age range

18 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

After consent, a research pharmacist will virtually monitor the participant's blood pressure until the 12-month follow up visit. The research pharmacists will have access to the participant's electronic medical records to monitor and document medications and clinic blood pressures for analysis . Participants will be asked to measure and return 14 blood pressure measurements (2x per day for 7 days) using our text messaging platform. They will be allowed to choose the times that they are sent reminders to measure their blood pressure. If a participant has blood pressure values sufficient for a hypertension diagnosis, the pharmacist will communicate via electronic medical record with the participant's primary care team. If they do not have a primary care provider, the pharmacist will facilitate finding one. The pharmacist will continue monitoring the participant and making recommendations to the primary care team through the electronic medical record to quickly adjust therapy to improve blood pressure control. The pharmacists will typically contact the participants (via participant's choice of phone, text, or email) every 2-3 weeks while their hypertension is uncontrolled. Once under control, the pharmacist will continue to contact the participant at least every 2 months to support adherence and reassess control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Biological mothers delivering at UIHC or attending a well-child visit for an infant between 1 month and 9 months
  • Preeclampsia during pregnancy
  • Preceived prenatal care at UIHC
  • Owns a smartphone

Exclusion criteria

  • Arm circumference greater than 17 inches
  • Prisoner status
  • Unable to provide own written informed consent

Treatment and study plan

Research Pharmacist

Behavioral

The goal of this intervention is to determine if allied health professionals will improve blood pressure in new mothers.

Primary outcomes

  1. Number of Subjects at Risk for Hypertension

    Time frame: Through study completion, an average of 12 months

    We will calculate the number of participants who are at risk for hypertension during the course of the intervention.

  2. Number of Subjects Exposed to a Screening Clinic

    Time frame: Through study completion, an average of 12 months

    We will calculate the number of participants who visited a screening clinic during the course of the intervention.

  3. Number of Subjects Screened at a Screening Clinic

    Time frame: Through study completion, an average of 12 months

    We will calculate the number of participants who were screened at a screening clinic during the intervention.

  4. Number of Subjects Followed-Up by the Research Pharmacist

    Time frame: Through study completion, an average of 12 months

    We will calculated the number of participants who were followed-up by a research pharmacist during the intervention.

  5. Number of Subjects Diagnosed with Hypertension

    Time frame: Through study completion, an average of 12 months

    We will calculate the number of participants who were diagnosed with hypertension by their provider during the intervention.

  6. Number of Subjects Treated for Hypertension, if Diagnosed

    Time frame: Through study completion, an average of 12 months

    We will calculate the number of participants who were treated for their hypertension diagnosis by their provider, if they were diagnosed with hypertension, during the intervention.

Study contacts

Contact information is provided by the study sponsor or research team.

Philip M Polgreen, MD

CONTACT

[email protected]

319-384-6194

Shelby L Francis, PhD

CONTACT

[email protected]

319-678-8037

Sponsors and collaborators

Lead sponsor

University of Iowa

Other

Registry information

Official study title

Use of Non-physician Allied-health Professionals to Recruit (and Follow) Research Participants, Sustain Engagement, and Improve and Diagnose Treatment of Diseases by Facilitating Transitions of Care

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Mar 29, 2024
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.